Research / CRS / Fundamental state Inspectable configuration
State dimensions Filing 0000017843-15-000026 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
27.26% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.66% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
2.47% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
29.45% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
14.29% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
5.01% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.84% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.45% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2018 7/8 normalized Level 3 Dec 31, 2018 7/8 normalized Level 3 Mar 31, 2019 8/8 normalized Level 3 Jun 30, 2019 8/9 normalized Level 3 Sep 30, 2019 8/8 normalized Level 3 Dec 31, 2019 8/8 normalized Level 3 Mar 31, 2020 8/8 normalized Level 3 Jun 30, 2020 7/8 normalized Level 3 Sep 30, 2020 8/8 normalized Level 3 Dec 31, 2020 8/8 normalized Level 3 Mar 31, 2021 8/8 normalized Level 3 Jun 30, 2021 7/8 normalized Level 3 Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Sep 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 106.87%
Current 27.26%
Delta -79.61% Capex Intensity Increased
Previous 4.35%
Current 7.66%
Delta 3.31% Growth Increased
Previous 0.76%
Current 2.47%
Delta 1.71% Inventory Pressure Decreased
Previous 124.55%
Current 29.45%
Delta -95.10% Margin Increased
Previous 13.28%
Current 14.29%
Delta 1.01% Profitability Increased
Previous 0.84%
Current 5.01%
Delta 4.17% Sbc Intensity Decreased
Previous 0.81%
Current 0.45%
Delta -0.36% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.